Management of abemaciclib-associated adverse events in patients with HR+/HER2-advanced breast cancer: analysis of the MONARCH trials

H. S. Rugo, J. Huober, A. Llombart-Cussac, M. Toi,S. Tolaney,V. Andre,S. Barriga, T. Forrester, Jr G. W. Sledge,M. P. Goetz

ONCOLOGY RESEARCH AND TREATMENT(2019)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要